Skip to main content
MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.721
-0.028 (-3.71%)
At close: Oct 30, 2024, 4:00 PM
0.749
+0.028 (3.86%)
After-hours: Oct 30, 2024, 7:08 PM EDT

MiNK Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
31
Market Cap
28.51M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019689.63K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FibroGen 173.82M
Outset Medical 116.43M
Neuronetics 72.07M
Burning Rock Biotech 70.15M
Curis 10.16M
Lipocine 4.80M
Onconetix 1.46M
IGC Pharma 1.06M
Revenue Rankings

INKT News

More News